Compare PACK & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PACK | ZVRA |
|---|---|---|
| Founded | 1972 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.2M | 472.9M |
| IPO Year | 2017 | 2015 |
| Metric | PACK | ZVRA |
|---|---|---|
| Price | $3.82 | $8.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $7.17 | ★ $21.71 |
| AVG Volume (30 Days) | 517.3K | ★ 550.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.27 |
| EPS | N/A | ★ 1.16 |
| Revenue | ★ $395,000,000.00 | $23,612,000.00 |
| Revenue This Year | $9.47 | $333.64 |
| Revenue Next Year | $9.54 | $44.19 |
| P/E Ratio | ★ N/A | $7.60 |
| Revenue Growth | ★ 7.08 | N/A |
| 52 Week Low | $2.91 | $6.19 |
| 52 Week High | $6.31 | $13.16 |
| Indicator | PACK | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 26.81 | 53.84 |
| Support Level | $3.26 | $8.61 |
| Resistance Level | $6.01 | $9.03 |
| Average True Range (ATR) | 0.34 | 0.36 |
| MACD | -0.15 | 0.02 |
| Stochastic Oscillator | 10.83 | 69.51 |
Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.